{"Title": "Inactivation of the Class II PI3K-C2\u03b2 Potentiates Insulin Signaling and Sensitivity", "Year": 2015, "Source": "Cell Rep.", "Volume": "13", "Issue": 9, "Art.No": null, "PageStart": 1881, "PageEnd": 1894, "CitedBy": 38, "DOI": "10.1016/j.celrep.2015.10.052", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84947604001&origin=inward", "Abstract": "\u00a9 2015 The Authors.In contrast to the class I phosphoinositide 3-kinases (PI3Ks), the organismal roles of the kinase activity of the class II PI3Ks are less clear. Here, we report that class II PI3K-C2\u03b2 kinase-dead mice are viable and healthy but display an unanticipated enhanced insulin sensitivity and glucose tolerance, as well as protection against high-fat-diet-induced liver steatosis. Despite having a broad tissue distribution, systemic PI3K-C2\u03b2 inhibition selectively enhances insulin signaling only in metabolic tissues. In a primary hepatocyte model, basal PI3P lipid levels are reduced by 60% upon PI3K-C2\u03b2 inhibition. This results in an expansion of the very early APPL1-positive endosomal compartment and altered insulin receptor trafficking, correlating with an amplification of insulin-induced, class I PI3K-dependent Akt signaling, without impacting MAPK activity. These data reveal PI3K-C2\u03b2 as a critical regulator of endosomal trafficking, specifically in insulin signaling, and identify PI3K-C2\u03b2 as a potential drug target for insulin sensitization.", "AuthorKeywords": null, "IndexKeywords": ["Adaptor Proteins, Signal Transducing", "Animals", "Autophagy", "Blood Glucose", "Cells, Cultured", "Class II Phosphatidylinositol 3-Kinases", "Diet, High-Fat", "Endosomes", "Fatty Liver", "Gene Knock-In Techniques", "Hepatocytes", "Insulin", "Liver", "Mice", "Mice, Inbred C57BL", "Mitogen-Activated Protein Kinases", "Phosphorylation", "Proto-Oncogene Proteins c-akt", "Signal Transduction"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84947604001", "SubjectAreas": [["Biochemistry, Genetics and Molecular Biology (all)", "BIOC", "1300"]], "AuthorData": {"15028431100": {"Name": "Alliouachene S.", "AuthorID": "15028431100", "AffiliationID": "60109234, 60022148", "AffiliationName": "UCL Cancer Institute, University College London"}, "7801342545": {"Name": "Bilanges B.", "AuthorID": "7801342545", "AffiliationID": "60109234, 60022148", "AffiliationName": "UCL Cancer Institute, University College London"}, "8528934800": {"Name": "Pearce W.", "AuthorID": "8528934800", "AffiliationID": "60109234, 60022148", "AffiliationName": "UCL Cancer Institute, University College London"}, "36724580900": {"Name": "Ali K.", "AuthorID": "36724580900", "AffiliationID": "60001673", "AffiliationName": null}, "50262737600": {"Name": "Posor Y.", "AuthorID": "50262737600", "AffiliationID": "60109234, 60022148", "AffiliationName": "UCL Cancer Institute, University College London"}, "56967606900": {"Name": "Low P.C.", "AuthorID": "56967606900", "AffiliationID": "60109234, 60022148", "AffiliationName": "UCL Cancer Institute, University College London"}, "22833893200": {"Name": "Chaussade C.", "AuthorID": "22833893200", "AffiliationID": "60025490", "AffiliationName": null}, "7004331309": {"Name": "Vanhaesebroeck B.", "AuthorID": "7004331309", "AffiliationID": "60109234, 60022148", "AffiliationName": "UCL Cancer Institute, University College London"}, "24330578000": {"Name": "Chicanne G.", "AuthorID": "24330578000", "AffiliationID": "60000905", "AffiliationName": "Inserm/UPS UMR 1048, Institut des Maladies M\u00e9taboliques et Cardiovasculaires"}, "56875441200": {"Name": "Valet C.", "AuthorID": "56875441200", "AffiliationID": "60000905", "AffiliationName": "Inserm/UPS UMR 1048, Institut des Maladies M\u00e9taboliques et Cardiovasculaires"}, "7006423284": {"Name": "Payrastre B.", "AuthorID": "7006423284", "AffiliationID": "60000905", "AffiliationName": "Inserm/UPS UMR 1048, Institut des Maladies M\u00e9taboliques et Cardiovasculaires"}, "56493775700": {"Name": "Anderson K.E.", "AuthorID": "56493775700", "AffiliationID": "60000661", "AffiliationName": "Inositide Laboratory, The Babraham Institute"}, "7102747513": {"Name": "Stephens L.", "AuthorID": "7102747513", "AffiliationID": "60000661", "AffiliationName": "Inositide Laboratory, The Babraham Institute"}, "35421301300": {"Name": "Hawkins P.T.", "AuthorID": "35421301300", "AffiliationID": "60000661", "AffiliationName": "Inositide Laboratory, The Babraham Institute"}, "57213660208": {"Name": "Scudamore C.L.", "AuthorID": "57213660208", "AffiliationID": "100592139", "AffiliationName": "Mary Lyon Centre, MRC Harwell, Harwell Science and Innovation Campus"}, "54788232000": {"Name": "Salamon R.S.", "AuthorID": "54788232000", "AffiliationID": "60002388", "AffiliationName": "Department of Molecular Pharmacology, Albert Einstein College of Medicine"}, "35597544800": {"Name": "Backer J.M.", "AuthorID": "35597544800", "AffiliationID": "60002388", "AffiliationName": "Department of Molecular Pharmacology, Albert Einstein College of Medicine"}}}